Wendy Ingram - Concepedia

Author

Wendy Ingram

King's College London

Also Known As

W Ingram, W. Ingram, Wendy A Ingram, Wendy Ingram, Trevor Pickersgill

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

King's College London King's College Hospital University Hospital of Wales University College London Cardiff University

About

Wendy Ingram is an author at King's College London specializing in medicine, immunology, and t cell immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	135
2	Immunology	5	5	88
3	Cell Biology	3	3	54
4	Cellular Therapies	1	1	16
5	Marrow Transplantation	1	1	16

Wendy Ingram

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) Shahram Kordasti, Wendy Ingram, Janet Hayden, Blood	2007	267
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes Azim Mohamedali, Joop Gäken, Natalie A. Twine, Blood	2007	194
IL‐17‐producing CD4<sup>+</sup>T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome Shahram Kordasti, Behdad Afzali, ZiYi Lim, British Journal of Haematology	2009	191
Neurological updates: neurological complications of CAR-T therapy Emma Tallantyre, Nia A. Evans, Jack Parry-Jones, Journal of Neurology	2020	82
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia Charles Craddock, Daniel Slade, Carmela De Santo, Journal of Clinical Oncology	2019	71
Outcomes of alemtuzumab‐based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes Zi Yi Lim, Aloysius Ho, Wendy Ingram, British Journal of Haematology	2006	55
Outcome of BEAM‐autologous and BEAM‐alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma Wendy Ingram, Stephen Devereux, Emma Das‐Gupta, British Journal of Haematology	2008	47
Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML Zi Yi Lim, Wendy Ingram, R. Brand, Bone Marrow Transplantation Hematological MalignancyTransplantationMedicineHigh-risk Myelodysplastic SyndromeHematology	2009	47
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML Jad Othman, Nicola Potter, Katya Mokretar, Leukemia	2023	45
Delayed attainment of full donor chimaerism following alemtuzumab‐based reduced‐intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes Zi Yi Lim, Laurence Pearce, Aloysius Ho, British Journal of Haematology	2007	38

Page 1